Sichuan Maker Biotechnology, an in-vitro diagnostic reagents producer, plans to acquire 24.2% stake in Jiashan JASDAQ Medical Device Co Ltd for CNY15m ($2.27m). The acquisition will increase Sichuan’s share in the company to 57.2%.
Breast cancer prognostic company, Sividon Diagnostics GmbH has been acquired by Myriad Genetics, a molecular diagnostic company based in the US.
Myriad Genetics has agreed to pay up to €50m ($55.61m), of which €35m ($38.93m) will be paid as an upfront payment and the remaining will be paid at performance-based milestones.
The transaction, which was closed on 31 May 2016, allows Myriad Genetics to add Sividon Diagnostics’ EndoPredict test, a popular breast cancer prognostic test, to its global oncology distribution thus enabling it to strengthen its oncology portfolio of high-value, personalised medicine products.
Yestar International Holdings Company plans to acquire a China-based medical device company from an independent third party
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData